Synthesis and Dual D2 and 5-HT1A Receptor Binding Affinities of 7-piperazinyl and 7-piperidinyl-3,4-dihydroquinazolin-2(1H)-ones

By  

Medicinal Chemistry, Vol. 10, Iss. 5, 2014-08 ,pp. : 484-496

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of acute and repeated treatment with a novel dopamine D 2 receptor ligand on l-DOPA-induced dyskinesias in MPTP monkeys

By Tahar A.H.   Ekesbo A.   Gregoire L.   Bangassoro E.   Svensson K.A.   Tedroff J.   Bedard P.J.  

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 247-254

Elsevier

Access to resources Recommend Favorite

New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

By Blandini Fabio   Armentero Marie-Therese  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 153-168

Informa Healthcare

Access to resources Recommend Favorite

Therapeutical Potential of CB2 Receptors in Immune-Related Diseases

By  

Current Molecular Pharmacology, Vol. 6, Iss. 3, 2013-11 ,pp. : 183-203

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 1-26

Bentham Science Publishers

Access to resources Recommend Favorite